SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant
15 references·0 citing·47 second hop
Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant (2016)Novel class of medications, orexin recept…Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials (2015)Suvorexant for Primary Insomn…Effects of suvorexant on sleep architecture and power spectral profile in patients with insomnia: analysis of pooled phase 3 data (2015)Effects of suvorexant on slee…Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials (2014)Suvorexant in Patients With I…Suvorexant for the treatment of insomnia (2014)Suvorexant for the treatment …Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? (2014)Suvorexant for insomnia: a sy…Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial (2014)Safety and efficacy of suvore…Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis (2014)Ramelteon for the treatment o…International Classification of Sleep Disorders-Third Edition (2014)International Classification …Drug Treatment of Primary Insomnia: A Meta-Analysis of Polysomnographic Randomized Controlled Trials (2014)Drug Treatment of Primary Ins…Effects of Suvorexant, an Orexin Receptor Antagonist, on Sleep Parameters as Measured by Polysomnography in Healthy Men (2013)Effects of Suvorexant, an Ore…Orexin receptor antagonism for treatment of insomnia (2012)Orexin receptor antagonism fo…Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study (2011)Twelve months of nightly zolp…Insomnia: Definition, Prevalence, Etiology, and Consequences (2007)Insomnia: Definition, Prevale…Sedative Hypnotics in Older People With Insomnia: Meta-Analysis of Risks and Benefits (2006)Sedative Hypnotics in Older P…Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits (2005)Sedative hypnotics in older p…ECDEU Assessment Manual for Psychopharmacology (1976)Validation of the Insomnia Severity Index as an outcome measure for insomnia research (2001)Diagnostic and Statistical Manual of Mental Disorders (2013)Review of Safety and Efficacy of Sleep Medicines in Older Adults (2016)S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen (2017)Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery (2018)Epidemiology of insomnia: what we know and what we still need to learn (2002)Diagnostic and Statistical Manual of Mental Disorders (2013)Advances in the management of chronic insomnia (2016)Sleep Medicine: Insomnia and Sleep. (2019)Daridorexant, a New Dual Orexin Receptor Antagonist to Treat Insomnia Disorder (2020)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Effect of Placebo Conditions on Polysomnographic Parameters in Primary Insomnia: A Meta-Analysis (2015)The Management of Chronic Insomnia Disorder and Obstructive Sleep Apnea: Synopsis of the 2019 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guidelines (2020)Efficacy and tolerability of pharmacological treatments for insomnia in adults: A systematic review and network meta-analysis (2023)Bias in meta-analysis detected by a simple, graphical test (1997)Measuring inconsistency in meta-analyses (2003)Suvorexant for the treatment of primary insomnia: A systematic review and meta-analysis (2016)Insomnia in Elderly Patients: Recommendations for Pharmacological Management (2018)Pharmacological Management of Insomnia (2021)A manual for standardized terminology, techniques and scoring system for sleep stages in human subjects (1968)The use of analogue scales in rating subjective feelings (1974)Subjective and Objective Sleepiness in the Active Individual (1990)Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials (2016)The orexin story and orexin receptor antagonists for the treatment of insomnia (2023)The Columbia–Suicide Severity Rating Scale: Initial Validity and Internal Consistency Findings From Three Multisite Studies With Adolescents and Adults (2011)Pharmacologic Treatment of Insomnia Disorder: An Evidence Report for a Clinical Practice Guideline by the American College of Physicians (2016)The assessment and management of insomnia: an update (2019)Safety and efficacy of daridorexant in patients with insomnia disorder: results from two multicentre, randomised, double-blind, placebo-controlled, phase 3 trials (2022)The American Academy of Sleep Medicine (AASM) Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications (2007)Diagnostic and Statistical Manual of Mental Disorders ( DSM ‐ IV ‐ TR ) (2010)Operating Characteristics of a Rank Correlation Test for Publication Bias (1994)Assessing the quality of reports of randomized clinical trials: Is blinding necessary? (1996)British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders (2010)Exercise training improves sleep quality in middle-aged and older adults with sleep problems: a systematic review (2012)Older Adults' Reasons for Using Technology while Aging in Place (2015)The European Insomnia Guideline: An update on the diagnosis and treatment of insomnia 2023 (2023)Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians (2016)Insomnia and Risk of Cardiovascular Disease (2017)International Classification of Sleep Disorders (2017)Insomnia as a predictor of mental disorders: A systematic review and meta-analysis (2018)Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? (1989)The MOS 36-Item Short-Form Health Survey (SF-36) (1993)The MOS 36-ltem Short-Form Health Survey (SF-36): III. Tests of Data Quality, Scaling Assumptions, and Reliability Across Diverse Patient Groups (1994)Prevalence, Demographics, and Psychological Associations of Sleep Disruption in Patients With Cancer: University of Rochester Cancer Center–Community Clinical Oncology Program (2009)The effects of physical activity on sleep: a meta-analytic review (2015)Sleep Duration and Quality: Impact on Lifestyle Behaviors and Cardiometabolic Health: A Scientific Statement From the American Heart Association (2016)
this work references cited by second hop

References

  • 2014International Classification of Sleep Disorders-Third Edition3,858 cited
  • 2007Insomnia: Definition, Prevalence, Etiology, and Consequences1,499 cited
  • 2005Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits1,158 cited
  • 2014Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial519 cited
  • 2012Orexin receptor antagonism for treatment of insomnia322 cited
  • 2014Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials301 cited
  • 2014Suvorexant for insomnia: a systematic review of the efficacy and safety profile for this newly approved hypnotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?250 cited
  • 2014Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis199 cited
  • 2013Effects of Suvorexant, an Orexin Receptor Antagonist, on Sleep Parameters as Measured by Polysomnography in Healthy Men162 cited
  • 2014Drug Treatment of Primary Insomnia: A Meta-Analysis of Polysomnographic Randomized Controlled Trials136 cited
  • 2011Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study94 cited
  • 2015Effects of suvorexant on sleep architecture and power spectral profile in patients with insomnia: analysis of pooled phase 3 data79 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2015
Suvorexant for Primary Insomnia: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials
78 cited
  • 2014Suvorexant for the treatment of insomnia59 cited
  • 2006Sedative Hypnotics in Older People With Insomnia: Meta-Analysis of Risks and Benefits57 cited
  • Cited by

    No citing works inside the corpus for this window.